An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)
Clinical trial NCT03391765 · TERMINATED
Trial details
- NCT number
- NCT03391765
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-24
- Primary completion
- 2019-12-13
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.